Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-0547

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71335-0547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713350547)

This is a description of a medication called Valsartan Hctz. It is a yellow oval 320/25mg tablet that should be stored at room temperature between 20-25°C (68°-77°F) and kept out of reach of children. It is manufactured by Macleods Pharmaceuticals Ltd. and comes in a bottle with 30 tablets. The label includes the NDC code and an expiration date (MM/YY).*

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

This appears to be a table of blood pressure readings in relation to a medication called Velsartan HCT. The table tracks SBP (systolic blood pressure) readings and lists dosages of the medication and a placebo. The goal is to keep SBP below 140 mmHg.*

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

This text appears to be describing the baseline blood pressure readings of individuals in a study. The study aims to evaluate the difference in blood pressure between a group taking Valsartan and Hydrochlorothiazide medication and a control group taking a placebo. The reading of the Diastolic Blood Pressure (DBP) is less than 90 mmHg for both groups, which means that none of the individuals have a high DBP. The medication group is taking Valsartan HCT 320/25 mg which contains 320mg of Valsartan and 25mg of Hydrochlorothiazide. The control group is taking only a placebo. The baseline DBP for both the groups is in the range of 95-105 mmHg.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

This appears to be a table showing different medication dosages and their effects on blood pressure, specifically baseline SBP (systolic blood pressure) measured in mmHg. The table includes Valsartan HCT, Valsartan, Hydrochlorothiazide, and a Placebo. There are also numerical values included for each medication that are likely related to the blood pressure readings. However, since the table is incomplete and contains multiple unreadable characters, it's difficult to interpret the data accurately.*

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

This appears to be a medication record or prescription label for an individual taking Valsartan HCT (a combination of Valsartan and Hydrochlorothiazide) for hypertension. The baseline DBP (Diastolic Blood Pressure) is recorded at 100 mmHg. The text indicates varying dosages for the medication and a placebo option, but no further information is available.*

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.